{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:49:32Z","timestamp":1781329772822,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jdcr.2017.09.020","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T22:02:10Z","timestamp":1522447330000},"page":"298-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Plurifocal cutaneous leishmaniasis during treatment with ustekinumab"],"prefix":"10.1016","volume":"4","author":[{"given":"Louva","family":"Rakotonarivo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Lons-Danic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Janier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2017.09.020_bib1","series-title":"Control of the leishmaniases: report of a meeting of WHO Expert Committee on the control of leishmaniases, Geneva 22-26 March 2010","first-page":"1","volume":"949","year":"2011"},{"issue":"2","key":"10.1016\/j.jdcr.2017.09.020_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.lpm.2010.09.023","article-title":"Traitement des leishmanioses en France: proposition d'un r\u00e9f\u00e9rentiel consensuel","volume":"40","author":"Buffet","year":"2011","journal-title":"Presse Med"},{"issue":"9625","key":"10.1016\/j.jdcr.2017.09.020_bib3","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"issue":"9625","key":"10.1016\/j.jdcr.2017.09.020_bib4","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jdcr.2017.09.020_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.semarthrit.2013.01.006","article-title":"Leishmaniasis during anti-tumor necrosis factor therapy: report of 4 cases and review of the literature (additional 28 cases)","volume":"43","author":"Guedes-Barbosa","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"3-4","key":"10.1016\/j.jdcr.2017.09.020_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10354-016-0527-1","article-title":"Cutaneous and visceral leishmaniasis during anti-TNF\u03b1 therapy","volume":"167","author":"Guarneri","year":"2017","journal-title":"Wien Med Wochenschr"},{"issue":"11","key":"10.1016\/j.jdcr.2017.09.020_bib7","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.168.11.5771","article-title":"The role of IL-12 in maintaining resistance to Leishmania major","volume":"168","author":"Park","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jdcr.2017.09.020_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5152\/tpd.2014.1401","article-title":"The current status of cutaneous leishmaniasis in Morocco","volume":"38","author":"Tlam\u00e7ani","year":"2014","journal-title":"Turkiye Parazitol Derg"},{"key":"10.1016\/j.jdcr.2017.09.020_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1051\/parasite\/2014014","article-title":"Cutaneous leishmaniasis in North Africa: a review","volume":"21","author":"Aoun","year":"2014","journal-title":"Parasite"},{"issue":"3","key":"10.1016\/j.jdcr.2017.09.020_bib10","first-page":"230","article-title":"Visceral leishmaniasis in a psoriatic arthritis patient treated with methotrexate","volume":"22","author":"Hadjipetrou","year":"2014","journal-title":"Infez Med"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512617302291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512617302291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:18:36Z","timestamp":1762474716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512617302291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2352512617302291"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2017.09.020","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plurifocal cutaneous leishmaniasis during treatment with ustekinumab","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2017.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}